Skip to main content
. 2018 Apr 3;8:5478. doi: 10.1038/s41598-018-23304-7

Figure 4.

Figure 4

Reserpine (RSP) pretreatment exhausts cardiac norepinephrine (NE) and partially reverses the protective effect of BRL44408 (BRL) on the heart in CLP-treated rats. Rats first received subcutaneous injections of RSP (4.5 mg/kg) or normal saline once a day for 2 consecutive days and were then exposed to CLP or sham surgery on the 4th day after the last RSP administration. BRL (1.5 mg/kg) or normal saline was injected intraperitoneally 4 h after CLP or sham surgery. Cardiac (A) and plasma (B) NE concentrations were detected by ELISA at 6 h after CLP or sham surgery. At 20 h after CLP or sham surgery, (C) left ventricular function was assessed in a Langendorff apparatus, the maximum rates of the rise (+dP/dt) and fall (−dP/dt) of the left ventricular pressure at 30 min after perfusion are shown; (D) The left ventricular phosphorylated cTnI (Ser23/24) levels were detected by Western blot analysis; Left ventricular (E) and plasma (F) tumor necrosis factor (TNF)-α concentrations were detected by ELISA; Left ventricular myocardial IκBα (G), p38 (H) and JNK (I) phosphorylation, caspase-3 activation (J) as well as MPO (K) and VCAM-1 (L) levels were detected by Western blot analysis. n = 7 for the sham or RSP group; n = 10 for the CLP, CLP+BRL, RSP+CLP+BRL and RSP+CLP groups. Statistical significance is shown as *P < 0.05.